Skip to main content
. 2013 Sep 17;48(8):668–679. doi: 10.1310/hpj4808-668

Table 5.

Drug-drug interactions for the approved oral multiple sclerosis drugs1,3,4

Drug interaction Dimethyl fumaratea Fingolimod Teriflunomide
Antineoplastic, immunosuppressive, or immunomodulating therapies X

CYP1A2 substrates (eg, duloxetine, alosetron, theophylline, tizanidine) X

CYP2C8 substrates (eg, repaglinide, paclitaxel, pioglitazone, rosiglitazone) X

Drugs that slow heart rate or atrioventricular conduction (eg, beta-blockers, diltiazem) X

Ketoconazole X

Oral contraceptives X

QT-prolonging drugs (eg, citalopram, chlorpromazine, haloperidol, methadone, erythromycin) X

Vaccines X X

Warfarin X
a

None reported in the product labeling for dimethyl fumarate.